Low-cost wearable test for early Alzheimer's detection

Digital biomarker for a low cost ambulatory test for early detection of Alzheimer's disease

['FUNDING_R01'] · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · NIH-11169991

A low-cost wearable EEG device aims to spot early signs of Alzheimer's in people with mild memory problems.

Quick facts

Phase['FUNDING_R01']
Study typeNih_funding
SexAll
SponsorUNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON (nih funded)
Locations1 site (HOUSTON, UNITED STATES)
Trial IDNIH-11169991 on ClinicalTrials.gov

What this research studies

You would wear a small, dry-electrode EEG device at home that records brain activity during daily life. Researchers will analyze the recordings for brief seizure-like activity and disruptions in brain network patterns and combine those signals into a digital biomarker. The project focuses on people with amnestic mild cognitive impairment to see if the combined marker predicts progression to Alzheimer's. Data collection includes at-home EEG sessions and clinic visits for baseline and follow-up assessments.

Who could benefit from this research

Good fit: Ideal participants are older adults with amnestic mild cognitive impairment or new memory concerns who can do at-home EEG recordings and attend occasional clinic visits.

Not a fit: People without cognitive complaints, those with advanced dementia, or those unable to use wearable EEG devices are unlikely to benefit directly from this research.

Why it matters

Potential benefit: If successful, this could enable affordable, noninvasive early detection of Alzheimer's risk so people can access care and plan sooner.

How similar studies have performed: Prior studies have shown EEG network changes and higher seizure prevalence in Alzheimer's, but combining epileptiform activity with network markers using ambulatory dry-EEG is largely novel and untested.

Where this research is happening

HOUSTON, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Conditions: Alzheimer disease dementia, Alzheimer disease detection, Alzheimer disease screening, Alzheimer syndrome

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.